Search
Iluka managing director David Robb.

Listed companies back 'accelerators'

Blue chip mineral sands miner Iluka Resources and small biotech Sun Biomedical are as different as chalk and cheese; but what they share, apart from a Perth base, is a willingness to invest in Western Australia’s emerging technology ‘accelerator’ programs.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Sign up for free emails

Complete your details below to receive our twice-daily news emails and our BN Weekender.

CAPTCHA
Thanks! This question prevents spammers...
Image CAPTCHA
Enter the characters shown in the image.

Add your comment

BNIQ sponsored byLPC cresa

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 29/12/17

1 year TSR5 year TSR
177thNorthern Star Resources72%41%
215thRegis Resources51%-0%
250thIluka Resources41%4%
305thSandfire Resources26%-3%
696 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

22/08/17
$38k Bought
01/03/17
$40k Bought
02/09/16
$792k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

6th↓Northern Star Resources$850.6m
7th↓Iluka Resources$779.3m
9th↑Regis Resources$547.2m
10th↓Sandfire Resources$534.7m
497 listed resources companies ranked by revenue.
Source: Morningstar

Remuneration from Iluka Resources

59thSteve Wickham$1.058m
63rdMatthew Blackwell$1.046m
70thAlan Tate$988k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer